Tuckson Reed Vaughn - Insider Non-Derivative Transactions at CTI BIOPHARMA CORP (CTIC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 26, 2023, Tuckson Reed Vaughn's relationship to CTI BIOPHARMA CORP (CTIC) is Director, and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTIC insiders.
Data Source: SEC.
Tuckson Reed Vaughn - Insider Non-Derivative Transactions of CTIC Common Stock
Tuckson Reed Vaughn - Insider Non-Derivative Transactions at CTIC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 27, 2023 | U -- (Common Stock) | 48639 | 9.1 | 0 |
| Dec 17, 2022 | G -- (Common Stock) | 43785 | 0 | 48639 |